Stocks and Investing Stocks and Investing
Wed, April 29, 2020

Andrew Berens Maintained (BPMC) at Buy with Decreased Target to $105 on, Apr 29th, 2020


Published on 2024-10-27 04:27:01 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $125 to $105 on, Apr 29th, 2020.

Andrew, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources